🔎 Trials Near Me

Akèy › Timò Nèwo-endokrin › Illinois › Chicago

Etid klinik pou Timò Nèwo-endokrin nan Chicago, IL

7 etid pou Timò Nèwo-endokrin ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Ap rekriteFaz 3
  • Investigative Site, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06881992

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • ak 1 plis
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • University of Chicago, Chicago
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Ap rekriteFaz 1/2
  • The University of Chicago, Chicago
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Ap rekriteFaz 1/2
  • University of Chicago, Chicago
Laj 18 a 85 · Tout sèks · Mizajou Jan 29, 2026 · NCT06055439

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Ap rekriteFaz 4
  • University of Chicago Medical Center, Chicago
Laj 18 a 64 · Tout sèks · Mizajou Jan 22, 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Chicago
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Timò Nèwo-endokrin nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.